11
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Phase II Trial of Ifosfamide in the Treatment of Metastatic Hormone-Refractory Patients with Prostatic Cancer

, , , &
Pages 477-481 | Published online: 11 Jun 2009

References

  • Silverberg E. Cancer statistics. CA 1985; 35: 10–56
  • Prostate Cancer, W J Catalona. Grune and Stratton, Orlando 1984
  • Reiner W J, Scott W W, Eggleston J C, et al. Long term survival after hormonal therapy for stage D prostate cancer. J Urol 1979; 122: 183–184
  • Scher H I, Sternberg C N. Chemotherapy of urologic malignancies. Sem Urol 1985; 3: 239–280
  • Scott W W, Johnson D E, Schmidt J E, et al. Chemotherapy of advanced prostatic carcinoma with cyclophosphamide or 5 fluorouracil: results of first national randomized study. J Urol 1975; 114: 909–911
  • Elder J S, Gibbons R P. Results of trials of the USA national prostatic cancer project. Therapeutic Principles in Metastatic Prostate Cancer, F Schroeder, B Richards. Alan R. Liss, New York 1985; 221–242, (EORTC Genitourinary group monograph 2, Part A)
  • Einhorn L H. An overview of chemotherapeutic trials in advanced cancer of the prostate. Urological Cancer, D G Skinner. Grune and Stratton, New York 1983; 89–100
  • Schmidt J D. Cytotoxic agents effective in prostate cancer. Semin Urol 1983; 1: 299–310
  • Torti F M, Carter S K. The chemotherapy of prostatic adenocarcinoma. Ann Intern Med 1980; 92: 681–689
  • Einsenberger M A, Simon R, O'Dwyer P J, et al. A reevaluation of nonhormonal cytotoxic chemotherapy in the treatment of prostatic carcinoma. J Clin Oncol 1985; 3: 827–841
  • Kasimis B S, Miller J B, Kaneshiro C A, et al. Cyclophosphamide versus 5FU, doxorubicine and mitomycin C in the treatment of hormone resistant metastatic carcinoma of the prostate: A preliminary report of randomized trial. J Clin Oncol 1985; 3: 385–392
  • Torti F M, Aston D, Lum B L, et al. Weekly doxorabicin in endocrine refractory carcinoma of the prostate. J Clin Oncol 1983; 1: 477–482
  • Gibbons R P. Prostate cancer chemotherapy. Cancer 1987; 60: 586–588

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.